- Home
- / Jiangsu Hengrui Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jiangsu Hengrui Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥48.2
2024-10-29
Market Capitalization
¥301.2 B
2024-10-29
Revenue
¥27.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.2B | 23.0B | 27.4B | 25.6B | 21.0B | 22.2B | 24.8B | 27.7B |
| Cost of goods sold | 2.3B | 2.9B | 3.3B | 3.7B | 3.5B | 3.5B | 3.8B | 4.4B |
| Gross profit | 14.8B | 20.2B | 24.1B | 22.0B | 17.6B | 19.1B | 23.9B | 27.0B |
| Gross profit margin, % | 87.5% | 88.2% | 85.9% | 83.7% | 86.1% | 96.5% | 97.3% | |
| Operating expense total | 10.4B | 14.0B | 17.4B | 17.7B | 14.1B | 14.3B | 16.7B | 18.0B |
| Depreciation and amortization | 381.4M | 618.5M | 448.4M | 495.6M | 539.1M | 666.5M | 722.3M | 803.4M |
| EBITDA | 4.5B | 6.1B | 6.7B | 4.3B | 3.5B | 4.7B | 7.1B | 8.9B |
| EBITDA margin, % | 26.6% | 24.6% | 16.7% | 16.5% | 21.3% | 28.8% | 31.9% | |
| EBIT | 4.1B | 5.6B | 6.4B | 3.9B | 3.1B | 4.2B | 6.6B | 8.4B |
| EBIT margin, % | 24.4% | 23.3% | 15.3% | 14.8% | 19.1% | 26.6% | 30.2% | |
| Interest income | 70.1M | 127.1M | 290.3M | 367.5M | 385.3M | 477.1M | 603.3M | 785.4M |
| Interest expense | 4.7M | 6.5M | 5.9M | 5.6M | 14.3M | |||
| Pre tax profit | 4.5B | 6.1B | 6.9B | 4.5B | 4.0B | 4.7B | 7.2B | 8.7B |
| Income tax expense | 437.9M | 729.3M | 586.6M | (17.7M) | 153.4M | 389.3M | 832.7M | 990.6M |
| Net Income | 4.1B | 5.3B | 6.3B | 4.5B | 3.8B | 4.3B | 6.3B | 7.7B |